Below are the financial statements of Fisher & Paykel Healthcare, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of NZD | 2025 | 2024 |
|---|---|---|
| Operating revenue | 2,021a | 1,742.8a |
| Cost of sales | -750.1a | -698.4a |
| Gross profit | 1,270.9a | 1,044.4a |
| Selling, general and administrative expenses | -534.4a | -492.8a |
| Research and development expenses | -226.9a | -198.2a |
| Total operating expenses | -761.3a | -691a |
| Operating profit | 509.6a | 353.4a |
| Revaluation of land | 0a | -98.1a |
| Profit before financing and tax | 509.6a | 255.3a |
| Financing income | 4.3a | 3.3a |
| Financing expense | -11.1a | -18.2a |
| Exchange gain/(loss) on translation of foreign currency assets and liabilities | 0.5a | -4.7a |
| Net financing expense | -6.3a | -19.6a |
| Profit before tax | 503.3a | 235.7a |
| Tax expense | -126.1a | -103.1a |
| Profit after tax | 377.2a | 132.6a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Fisher & Paykel Healthcare’s data sources below and access millions more through our Disclosure Search.